China has approved two coronavirus vaccines for experimental against the deadly virus for phase one and two clinical trials says China news agency in Xinhua.
According to the News Agency, the vaccines are being developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm) and Sinovac Research and Development Co., Ltd, a company based in Beijing.
READ ALSO: One-Third Of National Health Service Staff Test COVID-19 Positive
One of the Chinese medical experts had earlier warned that the Coronavirus infection vaccine currently being developed by China is just entering the first phase of the clinical trials, and it will probably take more than a year to finish it.
Clinical trials of the first vaccine developed in China began in mid-March, with 108 volunteers taking part in them.